Quantum Phar. Share Discussion Threads

[busterdog2] 23/9/2016 15:27

N+1 Singer reaffirmed their buy rating on shares of Quantum Pharma PLC (LON:QP) in a research note issued to investors on Wednesday morning, ...

[ali47fish] 16/9/2016 10:17

many thanks dacian- how do share options affect the price- sorry i am learning!

[ali47fish] 16/9/2016 09:03

is there any explanation for the recent falls anyone please?

[davr0s] 14/9/2016 17:38

I call stopping out today capital preservation rather than being impatient. Do the maths across your PF if all your big losers only lost 10%. You'd be quite surprised at the outcome when averaged across the PF due to the multiplier effect of regaining 20/30/40%+ drops. If the technicals improve I'll buy back in - maybe higher maybe lower but at least I can't suffer a 20-30% drop from here and no one knows where this is going to go. What is clear is that the big money isn't buying at the moment and the breakout failed

[cougar99] 14/9/2016 17:08

> patient investor ( if that exists anymore).

Indeed, in this 'instant' world then there are fewer patient investors (traders) .... but that can be an advantage to investors that have a longer term outlook

[cougar99] 14/9/2016 16:07

I'd take it as a possible buying opportunity .... so let's see what the share price is at this time next month .....

[davr0s] 14/9/2016 14:49

That's me out - breakout couldn't hold and falling on high volume now

[rjd1233] 13/9/2016 08:30

Current sells seem to disagree hazl.

[hazl] 13/9/2016 07:30

good point
but I think they are on the way back up at last.imo

[cottoner] 13/9/2016 07:28

Amazed that QP haven't issued some sort of statement wrt MED2002 , currently relying on FUM for any PR!

[cottoner] 13/9/2016 07:12

From today's FUM RNS

In October 2015, the Company signed an agreement with Quantum Pharma Plc under which MED2002 is available for prescription as a special. Specials are medicines that have not been authorised and which are requested and prescribed on a named patient basis by appropriately qualified doctors under their own authority. It is intended that MED2002 will remain available as a special until it gains marketing authorisation.

[napoleon 14th] 08/9/2016 10:03

Interesting developements both here & FUM, but.....

FUM are likeliest to do a licencing deal & take the downpayment & cashflow (commision) rather than doing it themselves. IMO Pfizer would love to bring it to market globally, & protect what's left of Viagra that way. FUM would be better protected against copies, which are bound to happen, as they have with Viagra.

FUM could become the ARM of pharmas that way, making loads of money without risk, & avoid having to get to critical mass globally to really make the full profit on MED2002.

I hold neither of these, but do see a parallel with SOU (Sound Energy) which I have held since '14 @ 12p(!). A giant prospect (Tendara) but too big for its' owner to go it alone? It leaves these companies to do the part they do best - "explore" for new products.

Still, an interesting situation as the ink is only dry on MED2002 as a "special"& QP. can prove themselves as a realistic partner at this stage.

[snape] 08/9/2016 08:49

FUM market cap now approaching that of QP. If the deal was so transformational for them surely worth an RNS here?

[cougar99] 08/9/2016 04:03

Well it's a third up from it's low in Spring ... but plenty more upside to come.

And the outcome on the positive effects of Vit D is on-going. This not related directly to QP:
All take-out sandwiches from Marks & Spencer are being fortified with Vitamin D – the sunshine vitamin. The move comes against the background of mounting evidence of the beneficial effects of the key nutrient.


And we have:
Vitamin D supplements could halve risk of serious asthma attacks

[miss womble] 07/9/2016 10:41

This deal with FUM must be good news for QP. I don't quite understand why the share price has not responded.

[meganxmas] 07/9/2016 08:52

Delighted too see FUM result today as bought in not too long ago based on recent company statements and underlying confidence. Took a wee nibble here today as well ... not sure how importnant contract with FUM is or could be ... but ...NAI \DYOR

[cottoner] 07/9/2016 08:19

Big announcement from FUM today wrt MED2002.

QP hod exclusive Licensing Agreement with Futura Medical plc

Quantum Pharma Plc (AIM: QP.), the growing service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, today announces that it has signed an exclusive agreement with Futura Medical plc (AIM: FUM) the healthcare company which is focused on advanced transdermal technology, to manufacture and make available MED2002, Futura's novel treatment for erectile dysfunction, as an unlicensed medicine (special) in the UK (the "Agreement").

Under the terms of the Agreement, Quantum has been granted exclusive rights to manufacture and supply MED2002 as a special in the UK. In return Quantum will pay to Futura undisclosed royalty payments on the sale of the product.

[alessxito] 05/9/2016 13:05

Next stop 100

[cougar99] 02/9/2016 15:42

Indeed ... it seems to be an 'instant' world nowadays .... not many people used to waiting for a bus on Sundays .... saw someone yesterday throw a hissy fit because they had just missed the metro and the board was showing 5 mins to the next one ..... however, I do have time to wait (both for this share and a bus on Sunday) ... :-)